406 related articles for article (PubMed ID: 25462173)
1. Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.
Henninger C; Huelsenbeck S; Wenzel P; Brand M; Huelsenbeck J; Schad A; Fritz G
Pharmacol Res; 2015 Jan; 91():47-56. PubMed ID: 25462173
[TBL] [Abstract][Full Text] [Related]
2. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
3. The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.
Henninger C; Huelsenbeck J; Huelsenbeck S; Grösch S; Schad A; Lackner KJ; Kaina B; Fritz G
Toxicol Appl Pharmacol; 2012 May; 261(1):66-73. PubMed ID: 22712078
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity.
Huelsenbeck J; Henninger C; Schad A; Lackner KJ; Kaina B; Fritz G
Cell Death Dis; 2011 Aug; 2(8):e190. PubMed ID: 21833028
[TBL] [Abstract][Full Text] [Related]
5. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.
Tocchetti CG; Carpi A; Coppola C; Quintavalle C; Rea D; Campesan M; Arcari A; Piscopo G; Cipresso C; Monti MG; De Lorenzo C; Arra C; Condorelli G; Di Lisa F; Maurea N
Eur J Heart Fail; 2014 Apr; 16(4):358-66. PubMed ID: 24464789
[TBL] [Abstract][Full Text] [Related]
7. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis.
Shaker RA; Abboud SH; Assad HC; Hadi N
BMC Pharmacol Toxicol; 2018 Jan; 19(1):3. PubMed ID: 29321061
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin.
Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X
Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936
[TBL] [Abstract][Full Text] [Related]
9. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
Zhang YY; Yi M; Huang YP
Cell Physiol Biochem; 2017; 43(2):626-635. PubMed ID: 28946137
[TBL] [Abstract][Full Text] [Related]
10. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
[TBL] [Abstract][Full Text] [Related]
11. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
Grant MK; Seelig DM; Sharkey LC; Zordoky BN
Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
[TBL] [Abstract][Full Text] [Related]
12. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
[TBL] [Abstract][Full Text] [Related]
13. Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits.
Jirkovský E; Lenčová-Popelová O; Hroch M; Adamcová M; Mazurová Y; Vávrová J; Mičuda S; Šimůnek T; Geršl V; Štěrba M
Toxicology; 2013 Sep; 311(3):191-204. PubMed ID: 23831762
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity.
Pecoraro M; Del Pizzo M; Marzocco S; Sorrentino R; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
Toxicol Appl Pharmacol; 2016 Feb; 293():44-52. PubMed ID: 26780402
[TBL] [Abstract][Full Text] [Related]
15. Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
Pei XM; Yung BY; Yip SP; Ying M; Benzie IF; Siu PM
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E311-23. PubMed ID: 24326424
[TBL] [Abstract][Full Text] [Related]
16. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
[TBL] [Abstract][Full Text] [Related]
17. Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
Jirkovsky E; Popelová O; Kriváková-Stanková P; Vávrová A; Hroch M; Hasková P; Brcáková-Dolezelová E; Micuda S; Adamcová M; Simůnek T; Cervinková Z; Gersl V; Sterba M
J Pharmacol Exp Ther; 2012 Nov; 343(2):468-78. PubMed ID: 22915767
[TBL] [Abstract][Full Text] [Related]
18. Effect of fermented Cordyceps sinensis on doxorubicin‑induced cardiotoxicity in rats.
Wu R; Yao PA; Wang HL; Gao Y; Yu HL; Wang L; Cui XH; Xu X; Gao JP
Mol Med Rep; 2018 Sep; 18(3):3229-3241. PubMed ID: 30066944
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice.
Oronsky B; Ao-Ieong ESY; Yalcin O; Carter CA; Cabrales P
Mol Pharm; 2019 Jul; 16(7):2929-2934. PubMed ID: 31038318
[TBL] [Abstract][Full Text] [Related]
20. 8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis.
Qin D; Yue R; Deng P; Wang X; Zheng Z; Lv M; Zhang Y; Pu J; Xu J; Liang Y; Pi H; Yu Z; Hu H
Biomed Pharmacother; 2021 Aug; 140():111779. PubMed ID: 34062415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
